HK1065705A1 - Method for manufacturing a low dose pharmaceuticalcomposition having uniform drug distribution and potency - Google Patents

Method for manufacturing a low dose pharmaceuticalcomposition having uniform drug distribution and potency

Info

Publication number
HK1065705A1
HK1065705A1 HK04108533A HK04108533A HK1065705A1 HK 1065705 A1 HK1065705 A1 HK 1065705A1 HK 04108533 A HK04108533 A HK 04108533A HK 04108533 A HK04108533 A HK 04108533A HK 1065705 A1 HK1065705 A1 HK 1065705A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceuticalcomposition
potency
manufacturing
low dose
drug distribution
Prior art date
Application number
HK04108533A
Other languages
English (en)
Inventor
Daniel Scott Gierer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1065705A1 publication Critical patent/HK1065705A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK04108533A 2001-05-01 2004-10-30 Method for manufacturing a low dose pharmaceuticalcomposition having uniform drug distribution and potency HK1065705A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28784101P 2001-05-01 2001-05-01
PCT/IB2002/000766 WO2002087546A2 (en) 2001-05-01 2002-03-13 Method for manufacturing a low dose pharmaceutical composition

Publications (1)

Publication Number Publication Date
HK1065705A1 true HK1065705A1 (en) 2005-03-04

Family

ID=23104578

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108533A HK1065705A1 (en) 2001-05-01 2004-10-30 Method for manufacturing a low dose pharmaceuticalcomposition having uniform drug distribution and potency

Country Status (44)

Country Link
US (2) US7037530B2 (uk)
EP (1) EP1383482B1 (uk)
JP (1) JP2004531537A (uk)
KR (1) KR100568380B1 (uk)
CN (1) CN1240375C (uk)
AP (1) AP2003002900A0 (uk)
AR (1) AR033288A1 (uk)
AT (1) ATE367152T1 (uk)
AU (1) AU2002236166B2 (uk)
BG (1) BG108297A (uk)
BR (1) BR0209283A (uk)
CA (1) CA2445519C (uk)
CZ (1) CZ20032959A3 (uk)
DE (1) DE60221238T2 (uk)
DK (1) DK1383482T3 (uk)
DO (1) DOP2002000389A (uk)
EA (1) EA005949B1 (uk)
EC (1) ECSP034826A (uk)
EE (1) EE200300537A (uk)
ES (1) ES2286226T3 (uk)
GE (1) GEP20053654B (uk)
GT (1) GT200200078A (uk)
HK (1) HK1065705A1 (uk)
HR (1) HRP20030858A2 (uk)
HU (1) HUP0401391A3 (uk)
IL (1) IL158390A0 (uk)
IS (1) IS6985A (uk)
MA (1) MA27017A1 (uk)
MX (1) MXPA03009391A (uk)
NO (1) NO20034709L (uk)
NZ (1) NZ528886A (uk)
OA (1) OA12596A (uk)
PA (1) PA8544401A1 (uk)
PE (1) PE20021137A1 (uk)
PL (1) PL366453A1 (uk)
PT (1) PT1383482E (uk)
SK (1) SK286536B6 (uk)
TN (1) TNSN03106A1 (uk)
TW (1) TWI264311B (uk)
UA (1) UA75135C2 (uk)
UY (1) UY27277A1 (uk)
WO (1) WO2002087546A2 (uk)
YU (1) YU81503A (uk)
ZA (1) ZA200307819B (uk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003209603B2 (en) 2002-03-28 2008-07-17 Pfizer Products Inc. Purified lasofoxifene and a method for purification of racemic lasofoxifene by recrystallization
PA8576201A1 (es) * 2002-07-10 2004-05-26 Pfizer Prod Inc Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
EP2023745A1 (en) * 2006-05-17 2009-02-18 WM. Wrigley Jr., Company Method of preparing a food product
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080351A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
WO2008074144A1 (en) * 2006-12-20 2008-06-26 Genpharm Ulc A composition containing a bisphosphonic acid in combination with vitamin d
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
LT2487166T (lt) 2007-02-23 2016-11-10 Gilead Sciences, Inc. Terapinių agentų farmakokinetinių savybių moduliatoriai
EA201591353A1 (ru) 2008-05-02 2016-01-29 Джилид Сайэнс, Инк. Применение частиц твердого носителя для улучшения технологических характеристик фармацевтического агента
WO2009135946A1 (en) * 2008-05-09 2009-11-12 Atacama Labs Oy Method and apparatus for dry granulation
EP2299987B1 (en) 2008-06-06 2018-02-21 Boehringer Ingelheim International GmbH Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
AU2010215646B2 (en) * 2009-01-29 2014-03-27 Ucb Biopharma Sprl Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
AU2010209790B2 (en) * 2009-01-29 2014-01-16 Ucb Pharma, S.A. Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
US20140350945A1 (en) * 2013-05-22 2014-11-27 Professional Compounding Centers Of America System and Method for Validation of Pharmaceutical Composition Formulations
CN103830196A (zh) * 2014-03-14 2014-06-04 王志刚 一种酒石酸拉索昔芬分散片及其制备方法
CN106176649B (zh) * 2016-08-31 2020-04-17 北京斯利安药业有限公司 叶酸vb12片及其制备方法
CA3053784A1 (en) * 2017-02-17 2018-08-23 Massachusetts Institute Of Technology Systems and methods for the fabrication of tablets, including pharmaceutical tablets
CZ309820B6 (cs) * 2021-04-23 2023-11-08 Pro.Med.Cs Praha A.S. Způsob přípravy pevné lékové formy obsahující kompozici s nízkým obsahem účinné látky

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725555A (en) * 1967-08-01 1973-04-03 Ciba Geigy Corp Bactericidal compositions and method of killing bacteria using bis-(phenoxyphenyl) carbonates
US3725556A (en) 1970-11-12 1973-04-03 D Hanssen Method of manufacturing rapidly disintegrating pharmaceutical tablets
US4013785A (en) 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
GB1570993A (en) * 1976-05-21 1980-07-09 Fisons Ltd Pharmaceutical tablet formulation
DE2845326C2 (de) 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4489026A (en) 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
US5004613A (en) 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5047246A (en) 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
US5107331A (en) * 1989-03-07 1992-04-21 The Color Group Method and apparatus for producing half-tone separations at the same screen angle
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
US5464632C1 (en) 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
US5928668A (en) 1993-12-21 1999-07-27 Applied Analytical Industries, Inc. Method for dry blend compression of medicaments
US5976570A (en) 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
ES2082723B1 (es) 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
ES2079327B1 (es) 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
GB9501127D0 (en) 1995-01-20 1995-03-08 Wellcome Found Tablet
US5726168A (en) * 1995-10-12 1998-03-10 Eli Lilly And Company Lipophilic benzothiophenes
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
US5733578A (en) 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
US5916916A (en) * 1996-10-10 1999-06-29 Eli Lilly And Company 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
CA2218756A1 (en) * 1996-10-25 1998-04-25 Kristin Sue Marron Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators
US6080427A (en) 1997-04-17 2000-06-27 Bristol-Myers Squibb Company Cefadroxil monohydrate tablet formulation
EP0889056B1 (en) 1997-07-01 2006-04-12 Pfizer Products Inc. Process for making a cyclodextrin
US6300367B1 (en) * 1999-04-20 2001-10-09 Protein Technologies International, Inc. Composition for and method of preventing or treating breast cancer
US6555551B1 (en) * 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos

Also Published As

Publication number Publication date
MA27017A1 (fr) 2004-12-20
UA75135C2 (en) 2006-03-15
EP1383482B1 (en) 2007-07-18
HUP0401391A2 (hu) 2004-12-28
CZ20032959A3 (cs) 2004-01-14
EA005949B1 (ru) 2005-08-25
NZ528886A (en) 2005-04-29
SK286536B6 (sk) 2008-12-05
EA200301040A1 (ru) 2004-04-29
KR100568380B1 (ko) 2006-04-05
IS6985A (is) 2003-10-09
HRP20030858A2 (en) 2005-08-31
DE60221238D1 (de) 2007-08-30
GEP20053654B (en) 2005-11-10
US7176221B2 (en) 2007-02-13
DE60221238T2 (de) 2007-10-31
YU81503A (sh) 2006-08-17
TWI264311B (en) 2006-10-21
AU2002236166B2 (en) 2006-12-07
IL158390A0 (en) 2004-05-12
PA8544401A1 (es) 2003-07-28
ATE367152T1 (de) 2007-08-15
SK13552003A3 (sk) 2004-09-08
US7037530B2 (en) 2006-05-02
GT200200078A (es) 2003-01-31
NO20034709D0 (no) 2003-10-21
ZA200307819B (en) 2004-10-07
KR20040015226A (ko) 2004-02-18
CA2445519A1 (en) 2002-11-07
PE20021137A1 (es) 2002-12-14
AR033288A1 (es) 2003-12-10
UY27277A1 (es) 2002-11-29
AP2003002900A0 (en) 2003-12-31
EE200300537A (et) 2004-04-15
BR0209283A (pt) 2004-07-13
PT1383482E (pt) 2007-09-20
OA12596A (en) 2006-06-08
BG108297A (bg) 2005-07-29
EP1383482A2 (en) 2004-01-28
DK1383482T3 (da) 2007-10-29
TNSN03106A1 (fr) 2005-12-23
CN1531423A (zh) 2004-09-22
US20060093667A1 (en) 2006-05-04
NO20034709L (no) 2003-10-31
CA2445519C (en) 2009-01-20
ES2286226T3 (es) 2007-12-01
US20030004182A1 (en) 2003-01-02
CN1240375C (zh) 2006-02-08
WO2002087546A3 (en) 2003-02-13
PL366453A1 (en) 2005-02-07
MXPA03009391A (es) 2004-01-29
JP2004531537A (ja) 2004-10-14
HUP0401391A3 (en) 2009-06-29
WO2002087546A2 (en) 2002-11-07
DOP2002000389A (es) 2002-11-30
ECSP034826A (es) 2004-02-26

Similar Documents

Publication Publication Date Title
HK1065705A1 (en) Method for manufacturing a low dose pharmaceuticalcomposition having uniform drug distribution and potency
IL152849A0 (en) Radiation delivery devices and methods for their manufacture
HUP0001949A3 (en) Refastenable packing and process for manufacturing refastenable packing
HK1053259A1 (en) A method and dosage form for dispensing a bioactive substance
IL149224A0 (en) Hydrogen-driven drug dosage form
IL154012A0 (en) Hydrogel-driven drug dosage form
EP1436042A4 (en) METHOD AND DEVICE FOR IONOPHORESIS ADMINISTRATION OF A MEDICINAL PRODUCT
EP1478345A4 (en) NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
AU2002341959A1 (en) Drug delivery devices and methods
IL138990A0 (en) Matrices for drug delivery and methods for making and using the same
AU2002319653A1 (en) Method for oral drug delivery
HK1046236A1 (zh) 迅速溶解的劑量形式及其生產方法
ZA200404838B (en) A method and device for reducing therapeutic dosage
HK1048598A1 (zh) 包衣藥物劑量形式的方法
HUP0303860A3 (en) A pharmaceutical tablet having a high active ingredient
AU2001286725A1 (en) A combinatorial method for rapid screening of drug delivery formulations
HUP0203443A3 (en) Novel contraceptive medicament and method for producing the same
IL156655A0 (en) Hormone replacement therapy method and its administration form
AU5654701A (en) Drug delivery mask
PL370378A1 (en) A pellet implant system and method of administration
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
AU3547001A (en) Method for producing pharmaceutical dosage forms
AU2001233844A1 (en) A method and apparatus for manufacturing a drug capsule for a needlefree injector
GB0005216D0 (en) Method and apparatus for drug delivery
GB9912683D0 (en) A method of tabletting dose units of active agents

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100313